Sutton Wealth Advisors Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$37,967
-0.3%
1,3550.0%0.01%
-12.5%
Q3 2022$38,076
-19.2%
1,3550.0%0.02%
-15.8%
Q2 2022$47,140
-3.1%
1,3550.0%0.02%
+11.8%
Q1 2022$48,645
+54.7%
1,355
+0.4%
0.02%
+70.0%
Q4 2021$31,442
+23.2%
1,350
+0.5%
0.01%
+11.1%
Q3 2021$25,530
-5.7%
1,3430.0%0.01%
-10.0%
Q2 2021$27,075
+10.0%
1,3430.0%0.01%0.0%
Q1 2021$24,604
+150.7%
1,343
+175.2%
0.01%
+150.0%
Q4 2020$9,814
+7.3%
4880.0%0.00%0.0%
Q3 2020$9,150
-16.5%
4880.0%0.00%
-33.3%
Q2 2020$10,960
+51.3%
4880.0%0.01%
+20.0%
Q1 2020$7,242
-23.1%
4880.0%0.01%0.0%
Q4 2019$9,414
-2.7%
4880.0%0.01%0.0%
Q3 2019$9,677
-6.1%
4880.0%0.01%
-16.7%
Q2 2019$10,302
+3.3%
4880.0%0.01%0.0%
Q1 2019$9,970
+2.7%
4880.0%0.01%0.0%
Q4 2018$9,711
+3.4%
4880.0%0.01%0.0%
Q3 2018$9,389
+26.1%
4880.0%0.01%
+20.0%
Q2 2018$7,447
-18.6%
4880.0%0.01%
-28.6%
Q1 2018$9,150
-2.5%
4880.0%0.01%0.0%
Q4 2017$9,389
+7.7%
4880.0%0.01%0.0%
Q3 2017$8,7214880.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders